Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 601 - 650 out of 1,387

Document Document Title
JP2004525799A
It has the substrate already covered with one or more reflective layers by the case of being advantageously transparent, A protection layer, other substrates, or a cover layer is prepared by one or more reflective layers and the case on ...  
JP2004525801A
Have the substrate already covered with the protection layer by the case of being advantageously transparent, and The information layer which can be written in by light on the surface of this substrate, a protection layer is provided wit...  
JP2004525798A
It has the substrate already covered with one or more reflective layers by the case of being advantageously transparent, A protection layer, another substrate, or a cover layer is 施与 (ed) by the information layer which can be written...  
JP2004234012A
To provide a charge transfer substance having an amino-substituted hydrozone group and an epoxy group, an organic photoreceptor and an electrophotographic image forming apparatus containing the substance, and a method for forming an elec...  
JPWO2002090342A1
本発明のクロメン化合物は、代表的には下記 式:で表される。このクロメン化合物は、発 色状体において440〜500nm、および 570〜630nmの2つの波長領域に...  
JP2004524199A
It has the substrate already covered with one or more reflective layers by the case of being advantageously transparent, A protection layer, other substrates, or a cover layer is prepared by one or more reflective layers and the case on ...  
JP2004524198A
It has the substrate already covered with one or more reflective layers by the case of being advantageously transparent, A protection layer, other substrates, or a cover layer is prepared by one or more reflective layers and the case on ...  
JP2004524194A
The optical data recording medium containing Co* phthalocyanine replaced in the direction of an axis in the information layer which can be written in with light. Use at least one Co (III) * phthalocyanine as a 吸光性 compound, and in ...  
JP2004524201A
The information layer in which optical writing is [already being covered with an one or more-layer reflective layer by the case] possible, It is an optical data storage medium which has the advantageously transparent substrate by which a...  
JP2004524195A
Already have one or more covered substrates by the case of being advantageously transparent, and on this substrate face, A protection layer, another substrate, or a cover layer is 施与 (ed) by the information layer which can be written...  
JP2004523396A
It has the substrate already covered with one or more reflective layers by the case of being advantageously transparent, A protection layer, other substrates, or a cover layer is prepared by one or more reflective layers and the case on ...  
JP2004523395A
It has the substrate already covered with one or more reflective layers by the case of being advantageously transparent, A protection layer, other substrates, or a cover layer is prepared by one or more reflective layers and the case on ...  
JPWO2004046275A
It is good and excels in carrier transport nature, and membrane formation nature is the material which shows luminescence in the state of a solid, and provides the electroluminescence element using the material for which it was suitable ...  
JP2004515549A
Compounds having the general structure:are effective antimicrobial agents.  
JP2004515548A
Compounds of the following formula:are effective antimicrobial agents.  
JPWO2002053543A1
カンナビノイド2型受容体親和性化合物とし て、式(I):(式中、R1は式:−Y1− Y2−Y3−Ra(式中、Y1は単結合等; Y2は−C(=O)−NH−等;Y3は...  
JP2004510712A
The invention features substituted fused bicyclic compounds, pharmaceutical compositions containing them, and methods of using them to treat or prevent histamine-mediated diseases and conditions.  
JP2004509785A
It has the support medium already covered with one or more reflective layers depending on the case of being advantageously transparent, Depending on the information layer which can be written in with light on the surface of this support ...  
JP2004509377A
Use of Co* phthalocyanine complex as an optical absorption compound to the information layer which can record the present invention by the light of the optical data storage medium in which 1-time record is possible, especially the optica...  
JP2004508356A
Disclosed are novel cathepsin S, K, F, L and B reversible inhibitory compounds of the formulas (I), (II), (Ia) and (Ib) further defined herein. The compounds are useful for treating autoimmune diseases. Also disclosed are processes for m...  
JP2004504494A
The present invention relates generally to a process for recovering copper and other metal values from metal-containing materials using controlled, super-fine grinding and medium temperature pressure leaching. Processes embodying aspects...  
JP2004503500A
The present invention relates to protoberberine derivatives which inhibit the activity of mitogen-activated protein kinase. More specifically, the present invention is directed to protoberberine derivatives which inhibit the activity of ...  
JP2004031318A
To provide an improved red emission type organic EL device.The organic electroluminescence device comprises an anode, a cathode and and at least one organic luminescent medium containing a compound expressed by a formula, wherein, R1 and...  
JP2004502771A
The present invention provides a compound of formula I which is useful as antiviral agents, in particular, as agents against viruses of the herpes family.  
JP3487611B2
PURPOSE: To obtain new compds. useful as dual inhibitors having inhibitory activity against angiotensin converting enzyme and neutral endopeptidase in the treatment of hypertension, congestive heart failure, hepatocirrhosis, etc. CONSTIT...  
JP2004002454A
To provide an inhibitor effective for inhibiting enterokinesis sthenia activity caused by a nonsteroidal antiinflammatory, and to provide an antiinflammatory pharmaceutical composition of which the enterokinesis sthenia activity is reduc...  
JP2003535865A
This invention provides novel caspase inhibitors of formula I: wherein R1 is hydrogen, CHN2, R, or —CH2Y; R is an aliphatic group, an aryl group, an aralkyl group, a heterocyclyl group, or a heterocyclylalkyl group; Y is an electronega...  
JP3453394B2
A compound of formula (I) wherein A is a substituent selected from the group consisting of wherein R min is hydrogen or methyl, m is zero or 1 and the @ @ means that the azabicyclic rings may be in the alpha or the beta orientation, and ...  
JP2003528097A
The present application describes novel beta-amino acid derivatives of formula I:or pharmaceutically acceptable salt or prodrug forms thereof, wherein A, X, Z, Ua, Xa, Ya, Za, R1, R2, R3, R4, and R4a are defined in the present specificat...  
JP2003176274A
To provide a method and an intermediate for producing an anticancer compound.This method comprises producing a compound represented by the formula 1 (wherein, R1, R2 and R15 are each defined in the specification) or its pharmaceuticallyp...  
JP3420549B2
To obtain an anticancer compound in a high yield useful for treating a highly proliferative disorder such as cancer in mammals by using a specific synthetic intermediate. (A) A compound of formula I [R1 and R2 are each a 1-10C alkyl, a 1...  
JP2003171278A
To provide a new and easy to synthesize apoptosis-inducing agent exhibiting the apoptosis-inducing activity against various cancer cell lines in a lower concentration and also exhibiting cytotoxicity in the lower concentration.This apopt...  
JP2003157978A
To provide an organic electroluminescence device using fluorochrome with low driving voltage, solidity, and excellent light emitting efficiency.For the organic electroluminescence device having a substrate on which, an organic layer and ...  
JP2003026586A
To provide a new TNF-α production inhibitor readily available as an ingredient derived from a plant, having high safety for the human body and capable of effectively inhibiting the production of the TNF-α not only from macrophages but ...  
JP3358749B2
PURPOSE: To provide a compound which exhibits a desirable green color in the darkened state and is capable of having a useful infrared absorbance at about 780 nm in the near infrared region in the state. CONSTITUTION: There is provided a...  
JP2002543169A
The present invention provides non-steroidal compounds of formula I which are selective modulators (i.e., agonists and antagonists) of a steroid receptor, specifically, the glucocorticoid receptor. The present invention also provides pha...  
JP2002338553A
To obtain a nitrogen-containing heterocyclic compound useful as a functional material, to provide a method for producing the same and to obtain an organic EL element using the compound.This nitrogen-containing heterocyclic compound can e...  
JP2002308876A
To provide a 4-oxoquinolizine compound having an antibacterial activity.This compound is represented by formula (I) (wherein R1 is H or a carboxy-protecting group; R2, is H, a halogen, a lower alkyl, a lower alkoxy or hydroxy; R3 to R6 a...  
JP3336024B2  
JP2002534526A
The present invention is a novel series of functionalized heterocycles as chemokine receptor modulators of Formula (I) useful as modulators of chemokine receptor activity. The compounds are useful in the treatment and prevention of the A...  
JP2002284779A
To obtain a compound capable of controlling production of inflammatory cytokine.This compound is represented by general formula (I) {A is a pyrrole ring; R1 is a substitutable aryl or a substitutable heteroaryl; R2 is a substitutable het...  
JP2002234892A
To provide an organic compound having absorption maximum in visible region, emitting visible light in red color area by exciting the compound and useful as a luminous agent and a light absorbent in organic electroluminescent element or t...  
JP2002234259A
To provide a recording material, contained in an optical recording medium, which can be applied to a DVD-R disc system using a semiconductor laser having an oscillated wave length on the short wave length side, compared to a conventional...  
JP2002226449A
To provide a charge transfer compound or the like having a hydrazone-bridged heterocyclic group linked through a central bridge group.This charge transfer compound is shown by the formula: (R-Q)n-Y [R is selected from the group consistin...  
JP2002212074A
To obtain an antiallergic agent and an antiinflammatory agent having excellent antiallergic actions and antiinflammatory actions with slight adverse effects.The antiallergic agent and the antiinflammatory agent comprise d-corydaline and/...  
JP2002522436A
Compounds of formula (I) or salt thereof or solvate thereof, in which: m is 1 or 2; n is 1 or 2; X is CH or N; Y is selected from hydrogen, halogen, cyano, CF3, alkyl or alkoxy; R<1>, which may be at any position within the saturated rin...  
JP2002522435A5  
JP2002522435A
The present invention refers to a process for the preparation of (1H)-benzo[c]quinolizin-3-ones derivatives of general formula (I) which involves only three steps and the use, as starting products, of commercially available, or easily pr...  
JP2002521337A
Benzo[b]quinolizidine and benzo[f]indolizidine derivatives are provided which are useful for the treatment of Alzheimer's disease, senile dementia or other conditions characterized by memory loss. Pharmaceutical compositions containing t...  
JP2002201130A
To obtain an agent capable of strongly inhibiting the formation of inflammatory cytokines and/or matrix metalloproteases such as IL-6, MMP-1 and PGE2 which are causes of various kinds of inflammatory diseases.This inhibitor of the format...  

Matches 601 - 650 out of 1,387